TThe Danish health authority is suspending the administration of Moderna’s COVID-19 vaccine to those under the age of 18, while Sweden announced today that it is doing the same for those under the age of 30, reports Reuters.
Both countries cited data showing a potentially increased risk of rare inflammatory heart disease known as myocarditis and pericarditis in younger people receiving Moderna vaccine, and recommended that people in those age groups receive the Pfizer / BioNTech vaccine instead obtain. Canadian vaccine data showed increased cases of heart inflammation, particularly among adolescents and young adults, after receiving the Moderna COVID-19 vaccine Spikevax, according to Reuters. Health experts from Sweden and Denmark claim that the risk of developing myocarditis or pericarditis remains low after taking Spikevax.
The U.S. Centers for Disease Control and Prevention notes that young men appear to be at higher risk of developing inflammatory diseases after receiving mRNA vaccines from Moderna or Pfizer, and that patients who develop these conditions after COVID-19 – Vaccination develops, tends to recover quickly. The agency also recommends that everyone 12 and older receive a COVID-19 vaccine, as the risks posed by COVID-19 far outweigh those associated with vaccination.
Denmark and Sweden are not alone, however; Norway had already recommended the Pfizer vaccine for men under 30, according to Reuters. Finland will announce a decision tomorrow.
“According to the precautionary principle, in future we will only invite children and young people to the reception [the Pfizer] Vaccine, not least in view of the fact that this vaccine has the largest amount of data on use in children and adolescents, especially from the US and Israel, ”Swedish health authority Bolette Soeborg told Associated Press.
Sweden had previously turned down Moderna in favor of Pfizer’s Corminaty vaccine for children ages 12-15, Reuters reported. “All in all, we see a reason to choose the vaccine that we know best about and that has proven to be the best vaccine for children between the ages of 12 and 15,” says Anders Tegnell, State Epidemiologist for the Swedish Health Department. said Reuters at the time.